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Carbamoylation is one of the post-PKSmodifications
in ansamitocin biosynthesis. A novel ansamitocino-
side with carbamoyl substitution at the C-4 hydroxyl
group of the N-b-D-glucosyl moiety was identified
from the ansamitocin producer, Actinosynnema
pretiosum. Through biotransformation, the carba-
moyltransferase gene asm21 was suggested to be
responsible for the carbamoylation of the glucosyl
moiety. Three new derivatives without the backbone
carbamoyl group were isolated from an asm21
mutant and characterized by NMR spectroscopy.
Among them, 18-O-methyl-19-chloroproansamitocin
was the major product and the preferred substrate
for macrolactam C-7 carbamoylation by Asm21.
However, Asm21 exhibited higher catalytic efficiency
toward the glucosyl moiety. Furthermore, the dual
carbamoylations and N-glycosylation were precisely
demonstrated in vivo. This work represents the first
biochemical characterization of an O-carbamoyl-
transferaseperformingdual actionsonboth apolyke-
tide backbone and a glycosyl moiety during ansami-
tocin biosynthesis.
INTRODUCTION
Carbamoylations are widespread in both primary and secondary
metabolism, and mostly take place at heteroatoms such as
oxygen or nitrogen. In antibiotic biosynthesis, althoughN-carba-
moylation has been found in some cases, O-carbamoylation is
relatively more common. It can be further divided into two types
according to the positions modified: (1), the C-3 or C-4 hydroxyl
group of hexose moieties, as in novobiocin and concanamycin A
(Gellert et al., 1976; Haydock et al., 2005; Kinashi et al., 1984;
Steffensky et al., 2000); or (2), a hydroxyl group of the nonsugar
backbone, as in ansamitocins (1) and cephamycin C (Higashide
et al., 1977; Miller et al., 1972; Nagarajan et al., 1971) (Figures 1A
and 1B). The presence of the carbamoyl group is essential for
antibiotic activity and cytotoxicity. An X-ray structure of theChemistry & Biology 18, 1571–158novobiocin-GyrB complex revealed interactions of the 30-O-
carbamoyl groupwith the amide nitrogen of Ala47, the side chain
of Asp73, and also three ordered water molecules in the ATP
binding site (Lewis et al., 1996). Removal of the carbamoyl group
led to a dramatic decrease in inhibitory activity (Flatman et al.,
2006; Hooper et al., 1982). The C-7/C-9 cyclic carbinolamide
group of maytansinoids was proposed to act as an alkylating
functionality involved in their antitumor activity. Blockage of
ring opening of the carbinolamide by alkylation of the C-9 alcohol
resulted in a marked decrease in antitumor activity and cytotox-
icity (Kupchan et al., 1978).
Maytansinoids are potent antitumor agents that exert
their cytotoxicity by disrupting microtubule assembly (Cassady
et al., 2004). Antibody conjugates of maytansinoids exhibit
increased tumor selectivity and longer circulation half-life and are
in different stages of clinical development (Chari, 2008). An-
samitocins, produced by Actinosynnema pretiosum ssp. auranti-
cumATCC31565, aremaytansinoidsofmicrobial origin (Higashide
et al., 1977). In the biosynthesis of ansamitocin P-3 (1), 3-amino-5-
hydroxybenzoic acid (AHBA) is used as a starter unit (Floss et al.,
2011), and the incorporation of seven PKS extender units gives
a 19-membered macrolactam, proansamitocin (9), which further
undergoes a series of post-PKS modifications, including O- and
N-methylation, chlorination, epoxidation, O-carbamoylation, and
O-acylation (Yu et al., 2002). Based on sequence homology,
gene asm21 in the biosynthetic gene cluster of ansamitocin was
assigned the putative function of introducing the cyclic carbinola-
mide group. An asm21-inactivated mutant accumulated several
compounds all lacking the carbamoyl group, indicating that
asm21 encodes a carbamoyltransferase (Spiteller et al., 2003).
Recently, ansamitocinosides P-1, P-2, and P-3 (AGP-1,
AGP-2, and AGP-3, 2) were isolated fromA. pretiosum cultivated
on solid yeast extract-malt extract-glucose (YMG) medium,
which carry a b-D-glucosyl moiety attached to the amide nitro-
gen in place of the N-methyl group of ansamitocins (Lu et al.,
2004; Ma et al., 2007; Zhao et al., 2008). Meanwhile, a series
of polar ansacarbamitocins with a glucosyl moiety and three car-
bamoyl groups were isolated from Amycolatopsis sp. CP2808
(Snipes et al., 2007) (Figure 1C). Later on, Asm25 was proved
to be the dedicated N-glycosyltransferase for the sugar
attachment, representing the first enzymatically active anti-
biotic N-glycosyltransferase purified from inclusion bodies in
Escherichia coli (Zhao et al., 2008). Moreover, two new0, December 23, 2011 ª2011 Elsevier Ltd All rights reserved 1571
Figure 1. Two Types of Carbamoylation and Structure of 400-O-Carbamoyl Ansamitocinoside P-3 (ACGP-3, 3)
(A) Antibiotics with carbamoylated sugar moieties.
(B) Antibiotics with carbamoylated nonsugar groups.
(C) AGP-3 (2), ACGP-3 (3), and ansacarbamitocin B. Carbamoyl groups on sugar moieties and nonsugar groups are highlighted in red and green, respectively.
See also Table S2.
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were assigned to beN-b-D-glucopyranosylated at themacrolac-
tam amide (Knobloch et al., 2011).
Herein, we report the isolation of a naturally carbamoylated
ansamitocinoside and the biochemical analysis of Asm21 action
toward both the polyketide backbone and the ansamitocinoside
sugar moiety.
RESULTS
Isolation and Structure Elucidation of 400-O-Carbamoyl
Ansamitocinoside P-3
By using an improved preparative TLC method (Ma et al., 2007),
a novel carbamoyl ansamitocin N-glycoside (3, 12 mg) was1572 Chemistry & Biology 18, 1571–1580, December 23, 2011 ª2011obtained as a straw yellow powder from the ethyl acetate extract
of A. pretiosum cultivated on solid YMGmedia (6 l). It was readily
determined by NMR comparison with AGP-3 (2) to be an ansa-
mycin of the ansamitocinoside-type (Table S2 available online).
The 13C-NMR and DEPT spectra of 3 showed 38 carbon signals
including 7 methyl, 4 methylene, 16 methine, and 11 quaternary
carbons, giving one more quaternary carbon signal (d 159.3) in
3 than in 2. The proton at d 3.10 (H-400) in 2 was shifted to
d 4.28 (H-400) in 3, indicating an acylation at the 400-hydroxyl group
(esterification effect). Themolecular formula of 3was determined
to be C38H52ClN3O15 based on the quasi molecular ion peak at
m/z 848.2988 [M + Na]+ recorded by high resolution electro-
spray ionization mass spectrometry (HR-ESI-MS) in positive
ion mode. Comparison of the molecular formula of 3 with thatElsevier Ltd All rights reserved
Figure 2. Carbamoylation of 2 through
Feeding Experiments with Resting Cells
(A) HPLC analysis of the resting cell cultures of
HGF068 and HGF051 fed with 2.
(B) MS profiles of the resting cell cultures
of HGF068 and HGF051 fed with 2. Ms, Mw of 2;
Mp, Mw of 3.
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in 3. The position of this carbamoyl group was located at
the 4-hydroxyl group of the b-D-glucopyranosyl moiety by
1H-13C long-range (HMBC) correlations between the proton
at d 4.28 (H-400) and the carbons C-500 (d 78.5), C-600 (d 62.9),
and NH2CO-4
00 (d 159.3), consistent with acylation at the
400-hydroxyl group as indicated by the 1H-NMR. Therefore,
3 was determined to be macrolactam amide N-desmethyl-N-b-
D-[4-O-carbamoyl]-glucopyranosyl ansamitocin P-3 (ACGP-3)
(Figure 1C).
Localization of Gene(s) for Carbamoylation of the C-400
Hydroxyl Group in Ansamitocinoside P-3
The isolation of carbamoylated ansamitocin N-glycosides
raised the question of what carbamoyltransferase(s) is(are)
responsible for these carbamoylation reactions. Two mutants
of A. pretiosum, HGF068 and HGF051, were used to discover
the carbamoyltransferase gene responsible for the carbamoy-
lation of 2. The production of ansamitocins or any intermedi-
ates was totally abolished in both strains because of the
absence of the PKS genes. The mutant HGF068 has a
200-kb deletion and lacks the whole asm gene cluster including
asm21, whereas the mutant HGF051 carries a deletion of the
PKS gene asmB but retains all the post-PKS modification
genes (Yu et al., 2002) (Table S1). Feeding experiments with
2 in resting cell cultures of HGF051 or HGF068 were performed
and the culture extracts were analyzed by LC-MS. Both
the quasi molecular ion peaks of 2 ([M + H]+ at m/z 783,
[M + Na]+ at m/z 805) and the expected quasi molecular ion
peaks of 3 ([M + H]+ at m/z 826, [M + Na]+ at m/z 848) were
detected in the HGF051 extract, whereas only 2 was found in
the HGF068 extract (Figure 2). The results indicate that the
gene(s) responsible for the carbamoylation of the glucosyl
moiety is(are) located in the 200-kb region, and asm21 is the
most likely candidate.Chemistry & Biology 18, 1571–1580, December 23, 2011 ªCharacterization of Four
Compounds Isolated from
the asm21 Mutant
An asm21-disrupted mutant, named
BLQ16, was constructed by the ReDirect
technology (Gust et al., 2003) to obtain
substrate for in vitro analysis of Asm21.
A 1929-bp internal fragment of asm21
was replaced with a 1384-bp disruption
cassette containing oriT and the apramy-
cin resistant gene aac(3)IV (Figure 3A).
PCR validation was performed using
genomic DNA of BLQ16 as template
and asm21-det-F/R as primers. As ex-
pected, the amplified product of BLQ16is 1.80 kb, whereas that of the wild-type is 2.30 kb (Figure 3B).
LC-MS analysis showed that the production of ansamitocins
was completely abolished in BLQ16. Furthermore, ansamitocin
productivity in the mutant was partly restored by complementa-
tion with the cloned asm21 gene under the control of the PermE*
promoter, confirming the involvement of asm21 in ansamitocin
biosynthesis (Figure 3C). In addition to the previously identified
19-chloroproansamitocin (5) (Spiteller et al., 2003), three novel
compounds were isolated from the culture of BLQ16 on solid
YMG medium and characterized by NMR (Figure 3D and Tables
S3–S5). From 6 l of solid culture, 60 mg 20-O-methyl-19-
chloroproansamitocin (8), 5 mg 19-chloroproansamitocin (5),
5.5 mg 14-b-hydroxy-20-O-methyl-19-chloroisoproansamitocin
(6), and 5.3 mg 14-a-hydroxy-20-O-methyl-19-chloroisoproan-
samitocin (7) were obtained (the configuration at C-14 of 6 and
7 may be interchanged). However, when BLQ16 was cultivated
in liquid YMG medium, 5 was the major product with all other
three components accumulated in lesser amounts as previously
reported (Spiteller et al., 2003). Therefore, it is worth investigating
whether 5 or 8 is the preferential substrate for Asm21.
Definition of Boundaries of asm21
For complementation of the asm21-disrupted mutant BLQ16,
the open reading frame (ORF) previously (Yu et al., 2002) pro-
posed for asm21 based on alignments with known carbamoyl-
transferases, was amplified and expressed under the control of
the strong constitutive PermE* promoter in pJTU839 (Figure S1
and Table S1). However, pJTU839 failed to restore ansamitocin
production. Re-analysis of the sequence using FramePlot 3.0
(Ishikawa and Hotta, 1999) revealed more potential start codons
in the upstream sequences. Thus the longest ORF with an addi-
tional 198-bp in the 50-region was chosen to ensure the integrity
of this gene in the new plasmid pJTU3053 (Figure S1 and
Table S1). As described above, complementation of BLQ16
with pJTU3053 restored ansamitocin production, indicating2011 Elsevier Ltd All rights reserved 1573
Figure 3. Inactivation and Complementation of asm21
(A) Schematic representation of asm21 inactivation by ReDirect technology. A 1929-bp internal fragment of asm21was replaced by a 1384-bp disruption cassette
containing oriT and the apramycin resistance gene aac(3)IV.
(B) PCR analysis of wild-type and mutant BLQ16. Using asm21-det-F/R as primers, the amplified product of BLQ16 was 1.80 kb, whereas that of the wild-type
was 2.30 kb.
(C) HPLC analysis of the wild-type, mutant BLQ16, and BLQ16 complemented with asm21 cloned under control of the PermE* promoter. See also Figure S1.
(D) Chemical structures of four compounds isolated from BLQ16, the configuration of 6 and 7 at C-14 may be interchanged. See also Tables S3–S5.
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bamoylation by Asm21.
Asm21 contains about 100 amino acids at its C terminus that
are absent in the carbamoyltransferases involved in some other
antibiotic biosynthesis. To probe whether this region of the
protein was essential for catalytic activity and what its role might
be, the 294-bp 30 terminus of asm21 was removed. However,
complementation using two truncated versions of asm21 failed
to restore ansamitocin production (Figure S1). Significantly
also, no accumulation of compounds with a linear carbamoyl
side chain was observed. Thus, the C-terminal 97 amino acids
of Asm21 are essential for the carbamoyl transferase activity of
the protein.
Asm21 Catalyzes the Carbamoylation of the C-7
Hydroxyl Group on the Ansamitocin Backbone
The intact asm21 fragment from pJTU3053 was cloned for
expression. Asm21 was expressed in E. coli BLR(DE3)pLysE1574 Chemistry & Biology 18, 1571–1580, December 23, 2011 ª2011as an N-terminally His6-tagged fusion protein in a yield of
300 mg/l culture as determined by Bradford protein assay (Fig-
ure S2A). The calculated molecular weight of native and His6-
tagged Asm21 is 80 kDa and 84 kDa, respectively. Based on
the results with BLQ16, 8 was chosen to examine the enzymatic
properties of Asm21 using carbamoyl phosphate as the second
substrate in the presence of Mg2+ and ATP (Freel Meyers et al.,
2004; Xu et al., 2004)., The reaction product was proven to beN-
desmethyl-4,5-desepoxy-maytansinol (4) by LC-MScomparison
with an authentic standard (Spiteller et al., 2003) (Figure 4A and
Figure S2B).
The product of the enzymatic reaction was quantitated
by HPLC with authentic 4 as an external standard. Based on
the reaction temperature profile from 10C to 50C, purified
Asm21 was optimally active at 37C, assaying at a protein
concentration of 1.6 mM in a 1 hr incubation. Comparable activ-
ities were exhibited between 30C and 40C andmore than 40%
of the maximal activity was retained above 50C (Figure S3A).Elsevier Ltd All rights reserved
Figure 4. Kinetic Characterization of Asm21
with 8 or 5 as Substrate
(A) HPLC analysis of assays with 8 as substrate.
Assay reactions were incubated at 30C overnight
with purified Asm21 or heat-denatured enzyme
as negative control. See also Figure S2 and Fig-
ure S3.
(B) Initial velocity of carbamoylation of 8 as
a function of the concentration of 8.
(C) Initial velocity of carbamoylation of 5 as
a function of the concentration of 5. All results
represent mean values of triplicate determinations
and standard deviations.
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Dual Carbamoylations of AnsamitocinsAsm21 showed optimal activity at pH 8.5–9.0, and more than
70% of the maximal activity in the pH range of 8.0–11.0. The
activity decreased dramatically at pH values lower than 7.5 (Fig-
ure S3B). Mg2+ was reported to be essential for the activity of
a carbamoyltransferase (Brewer et al., 1980). Asm21 consis-
tently showed the highest activity when supplied with 5–10 mM
Mg2+, considerable activity with 5 mM Mn2+ or Co2+, but no
activity with Ca2+, Zn2+, or Cu2+ (Figure S3C). Therefore, the
subsequent kinetic studies on Asm21 were performed at 37C
and pH 8.5 with 10 mM MgCl2 and 1 mM carbamoyl phosphate
as described in the Supplemental Information. Besides 8, Asm21
could also carbamoylate 5, 6, and 7 (Figures S2C and S2D).
The initial velocity was measured by varying the concentration
of 8 at a fixed concentration of carbamoyl phosphate (1mM). The
product concentration was quantitated by Q-TOF MS. Com-
pared to 5 with a Km of 78.7 ± 18.8 mM, Asm21 shows higher
affinity toward 8 with a Km of 25.2 ± 8.7 mM. The kcat values,
14.7 ± 1.1 s1 and 14.7 ± 1.2 s1 for 5 and 8, respectively, and
the catalytic efficiencies kcat/Km, 0.2 mM
1s1 for 5 and
0.6 mM1s1 for 8, also indicate that 8 is a preferred substrate
for Asm21 (Figures 4B and 4C).This is in accordance with the
intermediate accumulation pattern in solid cultures of BLQ16
(Figure 3A), albeit not in liquid cultures, which accumulate mainly
5 when Asm21 is inactivated (Spiteller et al., 2003).
Asm21 Catalyzes the Carbamoylation of C-4 Hydroxyl
Groupof theN-b-D-glucosylMoiety of Ansamitocinoside
P-3 (2)
The presumed substrate for carbamoylation, 2, was prepared by
in vitro glycosylation of PND-3 (11) with heterologously ex-
pressed soluble N-glycosyltransferase Asm25 (Zhao et al.,
2008). Asm21 catalyzed the conversion of 2 into 3 as detected
by Q-TOF MS (Figure 5A). Therefore Asm21 does have dual car-
bamoylation activity on both the polyketide backbone and the
sugar moiety. Moreover, Asm21 has a Km of 135.3 ± 38.4 mM
for 2, much higher than those for 5 or 8, which indicates a favored
binding mode placing the polyketide backbone rather than the
glucosyl moiety in the reaction site of Asm21 (Figure 5B).
However, it has a kcat of 212.5 ± 24.0 s
1 for 2, which is 14 timesChemistry & Biology 18, 1571–1580, December 23, 2011 ªhigher than those for 5 or 8. The overall
catalytic efficiency kcat/Km for 2 is
1.6 mM1s1 and thus higher than those
for 5 (0.2 mM1s1) or 8 (0.6 mM1s1).
Hence, the catalytic constants indicatethat Asm21 displays a preference for carbamoylation of the glu-
cosyl moiety over the polyketide backbone.
Dual Carbamoylations in Resting Cells
In order to demonstrate the dual action of Asm21 inA. pretiosum,
8was fed to resting cells of HGF068 lacking the whole asm gene
cluster and HGF051 that retains all the postmodification genes.
The production of 3 ([M + H]+ at m/z 826, [M + Na]+ at m/z 848)
was observed, and neither 8 nor the uncarbamoylated 2 was
detectable in HGF051, indicating the high dual catalytic effi-
ciency of Asm21. In addition, AP-3 (1), AP-2, AP-4, and quasi
molecular ion peaks proposed to belong to ACGP-2 ([M + Na]+
at m/z 834) and ACGP-4 ([M + Na]+ at m/z 862) were also
detected in the HGF051 extract. Meanwhile, no transformation
of 8 was observed in the HGF068 extract (Figure 6 and Figures
S4A–S4C).
DISCUSSION
The isolation of ansacarbamitocins (Snipes et al., 2007), carba-
moylated ansamitocin derivative (Knobloch et al., 2011), and
ACGP-3 (3) raised the question which gene and enzyme is
responsible for the carbamoylation of the glucose hydroxyl
group. The carbamoyltransferase-encoding gene asm21 within
the asm biosynthetic gene cluster was thought of as a potential
candidate. Otherwise, there must be other genes in the genome
to fulfill this function. The construction of numerous mutants of
A. pretiosum ATCC 31565 in the previous work (Yu et al., 2002)
allowed the convenient identification of the relevant functional
carbamoyltransferase gene(s). HGF051 is a mutant with a trun-
cated PKS asmB gene that retains the complete gene set for
post-PKS modifications, including asm21. HGF068 is a mutant
with a 200-kb deletion lacking the whole ansamitocin biosyn-
thetic gene cluster. Because HGF051 could convert AGP-3 (2)
into ACGP-3 (3) and HGF068 could not (Figure 2), the respon-
sible carbamoyltransferase gene must be located within the
200-kb region. Bioinformatic analysis of the 90-kb available
sequence of this region showed that asm21 is the only carba-
moyltransferase gene present. Asm21 had previously been2011 Elsevier Ltd All rights reserved 1575
Figure 5. Kinetic Characterization of Asm21
with 2 as Substrate
(A) Q-TOF MS profiles of assays with 2 as
substrate.
(B) Initial velocity of carbamoylation of 2 as
a function of the concentration of 2. Ms, Mw of 2;
Mp, Mw of 3. All results represent mean values of
triplicate determinations and standard deviations.
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hydroxyl group of the ansamitocin backbone and the formation
of the cyclic carbinolamide (Spiteller et al., 2003). Therefore the
feeding experiments suggested that Asm21 has dual carbamoy-
lation activity on both the polyketide backbone and the glucosyl
moiety.
The asm21 deletionmutant BLQ16 accumulated, in addition to
the previously isolated 5 and 8 (Spiteller et al., 2003), equal
amounts of two new compounds, 6 and 7, which are diastereo-
mers with opposite configurations at the newly generated ster-
eocenter (Figure 3). Their formation probably does not represent
a specific step in the ansamitocin biosynthetic pathway, but
rather a pathway-unspecific biotransformation of the accumu-
lated 8. When 8was fed to the resting cells of HGF068 (Figure 6),
it underwent substantial biotransformation, during which the
quasi molecular ion peaks corresponding to 6 and 7 ([M + Na]+
at m/z 530, [M + K]+ at m/z 546) could be found (Figure S4D).
This suggests that the biotransformation from 8 to 6 or 7 is
catalyzed by a general oxygenase encoded elsewhere in the
genome. Nevertheless, 6 and 7 are still substrates for carbamoy-
lation at C-7 by Asm21 (Figure S2D).1576 Chemistry & Biology 18, 1571–1580, December 23, 2011 ª2011 Elsevier Ltd All rights reIn the course of the complementation
experiments with the asm21-disrupted
mutant BLQ16, the previously proposed
(Yu et al., 2002) 2007-bp ORF for asm21
had to be revised to 2205-bp, extending
the amino terminus of the protein by 66
amino acids. This N-terminal 66-aa seg-
ment of Asm21 was found to be required
for carbamoyltransferase activity (Fig-
ure S1). However, because seven start
codons can be found in this 198-bp
region, more evidence is required to
define the precise start codon for the
translation of Asm21.
The cyclic carbinolamide group in
ansamitocin is different from the linear
carbamoyl groups in all other antibiotics.
Its installation requires a second reaction
after the carbamoylation at C-7, in which
the amino group reacts with the C-9 car-
bonyl group, resulting in a six-membered
ring and a free hydroxyl group. It is
unclear whether this second step occurs
spontaneously, as is chemically plau-
sible, or is also enzymatically catalyzed.
The asm biosynthetic gene cluster does
not contain any likely candidate gene to
encode such an enzyme. However, thefact that the C terminus of Asm21 is extended by 100 amino
acids compared to other antibiotic carbamoyltransferases
raised the question whether this region catalyzed the ring closure
reaction. Complementation of the asm21-disrupted mutant
BLQ16 with asm21 truncated at the C terminus by 97 amino
acids, however, failed to restore ansamitocin production (Fig-
ure S1), and did not lead to accumulation of compounds with
a linear carbamoyl side chain. Thus, this region of Asm21 is
essential for carbamoyltransferase activity, but probably not
for ring closure. The latter might occur spontaneously either
before or after release of the product of Asm21 from the enzyme.
In the post-PKS modification metabolic grid (Spiteller et al.,
2003), carbamoylation catalyzed by Asm21 can occur both
before and after O-methylation by Asm7, i.e., with 5 or 8 as
substrate. Our kinetic data on Asm21 demonstrate that 8 is
a 3-fold better substrate than 5, suggesting that more of the
flux through the grid proceeds via carbamoylation of 8. Subse-
quently in the pathway, the glucosyl moiety is transferred to
the macrolactam amide bond by the N-glycosyltransferase
Asm25, and Asm21 acts again to transfer the carbamoyl group
to the glucosyl moiety. Therefore, the tandem catalysis byserved
Figure 6. HPLC Analysis of the Conversion of 8 to 1 and 3 by Resting
Cells of A. pretiosum
See also Figure S4.
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biosynthetic pathway to carbamoylated ansamitocinosides
(Figure 7).
As both our studies and the work of the Kirschning group
show, Asm21 is an unusually promiscuous enzyme, which can
transfer the carbamoyl group to the C-7 OH group in a wide
range of structurally modified ansamitocins as well as to other
OH groups in various ansamitocin derivatives and analogs. As
shown by Knobloch et al. (2011), carbamoylation of the C-7
hydroxyl group by Asm21 will occur regardless of the substitu-
ents located in the aromatic western hemisphere. This is strongly
supported by the carbamoylation of compound 6 or 7 by Asm21
in our study. Whether Asm21 is also responsible for the addi-
tional carbamoylations at the benzyl alcohol function (Knobloch
et al., 2011) or other positions deserves further investigation
in vitro. Deeper insights into the enzymatic mechanism of the
multiple actions of Asm21 will require the X-ray structure deter-
mination of enzyme-substrate complexes to explain the impres-
sive substrate flexibility of this enzyme.
SIGNIFICANCE
The 400-O-carbamoyl ansamitocinoside (ACGP-3) isolated
from A. pretiosum ATCC31565 is a novel ansamitocin deriv-
ative that is carbamoylated on both the polyketide backbone
and the sugar moiety. The carbamoyltransferase Asm21
from the asm gene cluster was characterized by mutagen-
esis and complementation as well as heterologous expres-
sion and kinetic analysis. Remarkably, the enzyme catalyzes
not only the C-7 carbamoylation of the macrolactam back-
bone, accepting a variety of ansamitocin structures as sub-
strate, but also carbamoylation of the C-4 hydroxyl group of
the N-glucosyl moiety in ansamitocinoside P-3. The dual
action of Asm21was validated in vivo and in vitro, represent-
ing the first full characterization of an antibiotic O-carba-Chemistry & Biology 18, 1571–158moyltransferase with very high substrate flexibility. Thus,
the ansamitocin biosynthetic pathway could be extended
by cultivation on solid medium through the tandem catalysis
of the N-glycosyltransferase Asm25 and the O-carbamoyl-
transferase Asm21. Due to its broad substrate range,
Asm21 can be used to generate O-carbamoylated deriva-
tives of many ansamycins as potential drug candidates.
EXPERIMENTAL PROCEDURES
Bacterial Strains, Plasmids, and Primers
For a complete list, see Table S1 in theSupplemental Information.E. coli strains
DH10B (Invitrogen), ET12567/pUZ8002 and BLR(DE3)pLysE were used as
hosts for cloning, E. coli-Actinosynnema bi-parental conjugation and protein
overexpression, respectively. Plasmid pIJ2925 and pRSETb were used for
construction. Plasmid pJTU1289 was used for the construction of the asm21
mutant. The integrative vector pJTU824 was used for the complementation
of the asm21 mutant, and pRSETb was used for protein overexpression.
General Methods and Instrumentation
HPLCwas performed on aWaters 2690 Separations Module and a 996 Photo-
diode Array Detector. Mass spectra were measured on an Agilent 1100 Series
LC-MSD Trap. Preparative LC was carried out on a SHIMADZU LC-8A Prepar-
ative Liquid Chromatograph. Q-TOF MS analyses were performed on an Agi-
lent 6530 Accurate-Mass Q-TOF LC-MS. NMR spectra were recorded on
Bruker AM-400 or DRX-500 NMR spectrometers with TMS as internal stan-
dard. Silica GF254 for preparative plates and silica gel G precoated TLC plates
were obtained from Qingdao Marine Chemical Factory, Qingdao, China.
Sephadex LH-20 was purchased from Amersham Biosciences. C18 reversed
phase silica gel, 200–300 mesh, used for column chromatography was ob-
tained from Merck.
Actinosynnema pretiosum ssp. aurantium ATCC31565 and its derivatives
were cultivated in liquid or solid yeast extract-malt extract-glucose (YMG)
medium (0.4% yeast extract, 1% malt extract, and 0.4% glucose, pH 7.3)
for ansamitocin production. Fermentations and extractions were carried out
as described (Zhao et al., 2008). E. coli strains were cultivated at 37C in
Luria-Bertani medium or on Luria-Bertani agar plates. Total DNA was isolated
from Actinosynnema as described by Kieser et al. (2000). Synthesis of oligonu-
cleotide primers and DNA sequencing of PCR products were performed by
Shanghai Sangon and Invitrogen. Extraction of DNA fragments from agarose
gel slices was performed with the Gel Recovery Kit (Tiangen).
Isolation of Carbamoylated N-Ansamitocinoside (3, ACGP-3)
The solid culture agar of A. pretiosum was chopped up, diced, and extracted
four times with the solvent mixture EtOAc/MeOH/AcOH (80:15:5, v/v/v), at
room temperature. The residue of the extract (21 g) was subjected to MPLC
on C18 reversed-phase silica gel (145 g), eluting with water containing
increasing amounts of methanol, to produce four fractions (1–4). Fraction 2
(864 mg) was subjected to column chromatography on Sephadex LH-20
(130 g), eluting with MeOH, and then to MPLC on C18 reversed-phase silica
gel (45 g), eluting with water containing increasing amounts of MeOH to obtain
three fraction (2/1–2/3). Fraction 2/2 (240 mg) was dissolved in MeOH, and
then subjected to thin-layer chromatography using preparative plates (Qing-
dao, GF254) with EtOAc/MeOH (5:1, v/v), containing 0.5 ml 25% ammonia in
100 ml, as the developing solvent. Densitometric analyses of the chromato-
grams were carried out with a ternary wave-length TLC scanner ZF-I at
254 nm (Ma et al., 2007). All the TLC plates, for analysis and preparation,
were developed with the particular developing agent once or twice for optimal
separation. All the compounds were subjected to column chromatography
over Sephadex LH-20 (30 g) again eluting with acetone for purification.
1H NMR (400 MHz), 13C NMR (100 MHz), and 2-D NMR data are listed in
Table S2. 3, ESI m/z 848 [M + Na] +; HR-ESI-MS m/z 848.2988 [M + Na]+
(calculated for C38H52N3O15ClNa, 848.2984).
Resting Cell Preparation
A loopful of A. pretiosum, grown on YMG-agar, was used to inoculate 25 ml of
YMGmedia in a 250 ml Erlenmeyer flask, which was incubated for 24 hr (30C,0, December 23, 2011 ª2011 Elsevier Ltd All rights reserved 1577
Figure 7. The Extended Post-PKS Modifications of Ansamitocin Biosynthesis
Dotted arrows indicate the biotransformation from 8 to 6 or 7 is catalyzed by a pathway-nonspecific oxygenase encoded elsewhere in the genome.
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YMG (100 ml in a 500 ml Erlenmeyer flask). These batch cultures were incu-
bated for 48 hr before being harvested by centrifugation (7,000 rpm, 12 min).
The pellet was then washed three times with 0.2-volume equivalents of
distilled water, and the cells suspended in 0.2-volume equivalents of water.
The resting cell experiments were then initiated by adding the cell suspension
(20 ml) in a 80 ml mixture of lactose (0.25 M, 20 ml), MgCl2 (0.05 M, 10 ml),
L-valine (0.10 M, 10 ml), Tris-HCl (0.1 M, pH 8.0, 10 ml), and double distilled
water (30 ml). The cell density was now the same as prior to harvesting. The
cultures were incubated for 72 hr and harvested by direct extraction with ethyl
acetate (3-volume equivalent). The organic solvent was removed in vacuo, and
the residue was resuspended in methanol for LC-MS analysis.1578 Chemistry & Biology 18, 1571–1580, December 23, 2011 ª2011Inactivation of Carbamoyltransferase Gene asm21
The asm21 gene was disrupted using the ReDirect technology (Gust et al.,
2003). A 7509-bp SalI fragment carrying asm21 was cloned from cosmid
pDDc6 of the A. pretiosum ATCC 31565 genomic library into SalI-digested
pIJ2925 to generate pJTU825. The same fragment with two additional BglII
sites was then inserted into the BamHI site of pJTU1289 (He et al., 2010).
The asm21 gene from the resulting plasmid, pJTU8260, was replaced by
the aac(3)IV and oriT cassette amplified from the pIJ773 disruption cassette
with the primers asm21-del-F and asm21-del-R. The resulting pJTU827 was
introduced into ATCC 31565 via E. coli-Actinosynnema biparental conjuga-
tion as described (Yu et al., 2002). Apramycin-resistant and thiostrepton-
sensitive double crossover mutants were obtained after two rounds ofElsevier Ltd All rights reserved
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The mutant was confirmed by asm21-det-F and asm21-det-R and named
BLQ16.
Complementation of the asm21 Mutant BLQ16 with PCR-Amplified
asm21 of Different Lengths
Different lengths of asm21, 1.7-kb, 2.0-kb, 2.2-kb, were amplified from
pJTU825 using three pairs of primers: asm21-S-F/asm21-S-R, asm21-L-F/
asm21-S-R, and asm21-L-F/asm21-R, respectively. Engineered BamHI
and NdeI sites were contained in the forward primers, whereas an EcoRI
site was located in the reverse primers. The amplified fragments were
digested with BamHI and EcoRI and ligated into pRSETb, which had been
treated with the same enzymes, to generate pJTU831, pJTU838, and
pJTU3052, respectively. After sequencing, an internal 1661-bp BbsI frag-
ment of pJTU838 and pJTU3052 were replaced by the same fragment
from pJTU825 to ensure the complete sequence fidelity. An 1878-bp
BamHI-BstXI fragment from pJTU3052 and an 2987-bp BamHI-BxtXI frag-
ment were recovered and ligated together to generate pJTU3054 containing
1.9-kb asm21 that could also be amplified using asm21-L-F/asm21-S-R.
1.7-kb, 1.9-kb, 2.0-kb, 2.2-kb DNA fragments containing asm21 were
cleaved from pJTU831, pJTU3054, pJTU838, and pJTU3052 by NdeI and
EcoRI and cloned into pJTU824 (Wu et al., 2011b) to generate pJTU832,
pJTU3055, pJTU839, and pJTU3053, respectively. All the plasmids were
introduced into BLQ16 by conjugation. After incubation at 37C for 12 hr,
the plates were overlaid with 1 ml deionized water containing 1 mg nalidixic
acid, 1 mg apramycin, and 250 mg thiostrepton. The thiostrepton-resistant
exconjugants were confirmed by PCR using primers tsr-F/R for the thiostrep-
ton resistance gene (tsr), and the fermentation broths were then analyzed by
LC-MS.
Isolation and Structure Elucidation of Compounds from BLQ16
A seed culture of BLQ16 was prepared in liquid TSBY medium inoculated with
freshmycelia grown on YMG agar plates. After cultivation at 30C and 220 rpm
for 48 hr, 1ml each of the culture was used to inoculate 70ml YMG agar plates,
6 l in total. After fermentation at 30C for 9 days, the agar was chopped
into small pieces and extracted three times with EtOAc/MeOH/AcOH
(80:15:5, v/v/v) to obtain a crude extract. The extract was subjected to macro-
porous resin XAD-16 (Amberlite), which was washed with 45% ethanol and
eluted with 60% ethanol. The 60% ethanol eluate was concentrated, dissolved
in 2 ml methanol and then injected in 200 ml samples onto a preparative
SHIMADZU PRC-ODS column (55% methanol, flow rate: 4 ml/min, UV:
236 nm). The eluates were collected manually to give five fractions. Fractions
B, C, D, and Ewere examined by LC-MS for the presence of the corresponding
[M + H]+ or [M + Na]+ quasi molecular ion peak of the expected 5 or 8 and the
two new peaks of 6 and 7. All four fractions were subjected to a second HPLC
purification under the same conditions. The purified compounds were
analyzed by NMR and further used for the biochemical analysis. The NMR
data are listed in Tables S3–S5.
Isolation of 4 and Preparation of AGP-3
N-Desmethyl-4,5-desepoxy-maytansinol (4) was isolated from the asm19
mutant HGF052 as described previously (Wei et al., 2010). AGP-3 (2) was ob-
tained by scale-up of the conversion of 11 (PND-3, isolated from the asm10
mutant) and UDP-glucose catalyzed by purified soluble Asm25 expressed in
a pET28a derivative vector (Wu et al., 2011a; Zhao et al., 2008).
LC-MS Analysis of Ansamitocins and Derivatives
LC-Electrospray ionization (ESI)-MS analysis was performed on an Agilent
1100 series instrument with an Agilent ZORBAX SB-C18 column (2.1 3
150 mm, 3.5 mm). The UV detection wavelengths were 254 nm and 236 nm.
ESI mass spectrometry was carried out using chamber settings as follows:
nebulizer pressure, 30 psi; drying gas flow, 10 l/min; drying gas temperature,
325C. Samples were dissolved in methanol and analyzed at a flow rate of
0.1 ml/min with the following step gradient: 0–10 min 10% B, 10–20 min
55% B, 20–35 min 75% B, 35–45 min 90% B (solvent A, 99.8% water, 0.2%
formic acid; solvent B, methanol). Analysis was carried out in positive ion
mode with a mass range set to 400–900 Da.Chemistry & Biology 18, 1571–158Heterologous Expression and Purification of Recombinant
His6-Tagged Asm21
Transformants of E. coli BLR(DE3)pLysE harboring pJTU3052 were grown in
LB medium supplemented with ampicillin (100 mg/ml), chloramphenicol
(34 mg/ml), and tetracycline (12.5 mg/ml) overnight at 30C, 220 rpm. Five ml
of overnight culture was diluted with 150 ml fresh LBBS medium (10 g of tryp-
tone, 5 g of yeast extract, 10 g of NaCl, 182.2 g of D-sorbitol, 0.309 g of betaine
per liter) in a 500 ml flask (Eads et al., 1999). The culture was grown at 30C for
12 hr, at 16C for 12 hr to OD600 = 0.8–1.0, and induced with 0.1 mM IPTG at
16C for another 24 hr. After induction, the E. coli cells from 1 l culture were
centrifuged at 7,000 rpm for 30 min and the pellet was suspended in 50 ml
buffer A (20 mM Tris-HCl, pH 8.0, 300 mM NaCl) supplemented with an
EDTA-free Protease Inhibitor Cocktail Tablet (Roche). After disruption by three
passes through a French Press (Thermo), the cell debris was removed by
centrifugation (12,500 rpm, 40 min). The protein was purified from the soluble
cell extract by metal affinity chromatography using His-Bind Resin (Merck-
Novagen) according to the manufacturer’s instructions. The fractions were
eluted by buffer A containing 100 mM, 150 mM, 200 mM, or 1 M imidazole,
up to 100 ml in total, and concentrated to 1 ml in buffer A in a 50-kD Amicon
Ultra-15 Centrifugal Filter (Millipore). Protein concentrations were determined
by the Bradford method (Tiangen, PA102) with bovine serum albumin (BSA) as
standard. SDS-PAGE was carried out according to the method of Laemmli,
and protein bands were stained with Coomassie Brilliant Blue R250.
Enzymatic Assays and Identification of the Products
The carbamoyltransferase assay mixture contained 50 mM Tris-HCl (pH 8.0),
200 mM NaCl, 5 mM MgSO4, 2 mM DTT, 1% BSA, 5% DMSO, 2 mM ATP,
1 mM carbamoyl phosphate disodium, 0.5 mM 8, and purified Asm21 (1 mM)
in a final volume of 200 ml. The reactions were carried out at 30C overnight
and terminated by addition of 200 ml ethyl acetate. The assay products were
extracted twice with ethyl acetate. After evaporation of the organic solvent,
the residues were dissolved in methanol and analyzed by LC-MS as described
above.
Quantification and Kinetic Analysis
Enzymatic assays with 8 were carried out in a total volume of 100 ml as above,
containing typically 0.3–3.2 mMof Asm21. The reactions were carried for a suit-
able time interval during which the rate of product formation was linear with
time (10–60 min) and quenched with 50 ml n-butanol. After centrifugation at
12,000 rpm for 10 min, 10 ml aliquots of supernatant were analyzed by analyt-
ical HPLC (Waters) with an XTerraTM RP18 column (Waters, 5 mm, 3.9 3
150 mm; 55% methanol, 0.2 ml/min). The UV absorption of authentic 4 was
integrated automatically by software Millennium32 (Waters) based on a stan-
dard curve. The concentration of 4 in the reaction mixture was then calculated.
Kinetic parameters of 2, 5, and 8were determined with constant concentra-
tion of carbamoyl phosphate (1 mM). The concentration of substrates varied
between 10 and 500 mM. The reactions were carried out at optimal conditions
with an Asm21 concentration of 1 mM and terminated by addition of 100 ml
n-butanol. After centrifuged at 12,000 rpm for 10 min, 20 ml aliquots of the
supernatants were diluted to 1 ml with methanol and then quantified by
Q-TOF MS. The expected quasi molecular ion was extracted from the total
ion chromatogram (TIC), and calibrated by the Agilent MassHunter Qualitative
Analysis Software. The calibration curve was constructed based on peak
areas of each carbamoylated product at m/z 848, 543, and 557 [M + Na]+
for 2, 5, and 8, respectively. The initial concentration of the product was
then calculated according to the calibration curves. All the experiments were
performed in triplicate. Km and kcat values were determined with the GraphPad
Prism 5 software (Neumann et al., 1996).
SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures, and five tables and can be
found with this article online at doi:10.1016/j.chembiol.2011.11.007.
ACKNOWLEDGMENTS
The authors are grateful to Prof. Heinz G. Floss and Yuemao Shen for critical
discussions and help in manuscript preparation. This work received financial0, December 23, 2011 ª2011 Elsevier Ltd All rights reserved 1579
Chemistry & Biology
Dual Carbamoylations of Ansamitocinssupport from the National Natural Science Foundation of China, the Ministry of
Science and Technology (973 and 863 Programs), the Ministry of Education,
and the Shanghai Municipality.
Received: October 4, 2011
Revised: October 29, 2011
Accepted: November 7, 2011
Published: December 22, 2011REFERENCES
Brewer, S.J., Taylor, P.M., and Turner, M.K. (1980). An adenosine
triphosphate-dependent carbamoylphosphate—3-hydroxymethylcephem O-
carbamoyltransferase from Streptomyces clavuligerus. Biochem. J. 185,
555–564.
Cassady, J.M., Chan, K.K., Floss, H.G., and Leistner, E. (2004). Recent devel-
opments in themaytansinoid antitumor agents. Chem. Pharm. Bull. (Tokyo) 52,
1–26.
Chari, R.V. (2008). Targeted cancer therapy: conferring specificity to cytotoxic
drugs. Acc. Chem. Res. 41, 98–107.
Eads, J.C., Beeby, M., Scapin, G., Yu, T.W., and Floss, H.G. (1999). Crystal
structure of 3-amino-5-hydroxybenzoic acid (AHBA) synthase. Biochemistry
38, 9840–9849.
Flatman, R.H., Eustaquio, A., Li, S.M., Heide, L., and Maxwell, A. (2006).
Structure-activity relationships of aminocoumarin-type gyrase and topoisom-
erase IV inhibitors obtained by combinatorial biosynthesis. Antimicrob. Agents
Chemother. 50, 1136–1142.
Floss, H.G., Yu, T.W., and Arakawa, K. (2011). The biosynthesis of 3-amino-5-
hydroxybenzoic acid (AHBA), the precursor of mC7N units in ansamycin and
mitomycin antibiotics: a review. J. Antibiot. 64, 35–44.
Freel Meyers, C.L., Oberthu¨r, M., Xu, H., Heide, L., Kahne, D., and Walsh, C.T.
(2004). Characterization of NovP and NovN: completion of novobiocin biosyn-
thesis by sequential tailoring of the noviosyl ring. Angew. Chem. Int. Ed. Engl.
43, 67–70.
Gellert, M., O’Dea, M.H., Itoh, T., and Tomizawa, J. (1976). Novobiocin and
coumermycin inhibit DNA supercoiling catalyzed by DNA gyrase. Proc. Natl.
Acad. Sci. USA 73, 4474–4478.
Gust, B., Challis, G.L., Fowler, K., Kieser, T., and Chater, K.F. (2003). PCR-
targeted Streptomyces gene replacement identifies a protein domain needed
for biosynthesis of the sesquiterpene soil odor geosmin. Proc. Natl. Acad. Sci.
USA 100, 1541–1546.
Haydock, S.F., Appleyard, A.N., Mironenko, T., Lester, J., Scott, N., and
Leadlay, P.F. (2005). Organization of the biosynthetic gene cluster for the mac-
rolide concanamycin A in Streptomyces neyagawaensis ATCC 27449.
Microbiology 151, 3161–3169.
He, Y., Wang, Z., Bai, L., Liang, J., Zhou, X., and Deng, Z. (2010). Two
pHZ1358-derivative vectors for efficient gene knockout in streptomyces.
J. Microbiol. Biotechnol. 20, 678–682.
Higashide, E., Asai, M., Ootsu, K., Tanida, S., Kozai, Y., Hasegawa, T., Kishi,
T., Sugino, Y., and Yoneda, M. (1977). Ansamitocin, a group of novel maytan-
sinoid antibiotics with antitumour properties from Nocardia. Nature 270,
721–722.
Hooper, D.C., Wolfson, J.S., McHugh, G.L., Winters, M.B., and Swartz, M.N.
(1982). Effects of novobiocin, coumermycin A1, clorobiocin, and their analogs
on Escherichia coli DNA gyrase and bacterial growth. Antimicrob. Agents
Chemother. 22, 662–671.
Ishikawa, J., and Hotta, K. (1999). FramePlot: a new implementation of the
frame analysis for predicting protein-coding regions in bacterial DNA with
a high G + C content. FEMS Microbiol. Lett. 174, 251–253.1580 Chemistry & Biology 18, 1571–1580, December 23, 2011 ª2011Kieser, T., Bibb, M.J., Buttner, M.J., Charter, K.F., and Hopwood, D.A., eds.
(2000). Practical Streptomyces Genetics (Norwich, United Kingdom: The
John Innes Foundation).
Kinashi, H., Someno, K., and Sakaguchi, K. (1984). Isolation and characteriza-
tion of concanamycins A, B and C. J. Antibiot. 37, 1333–1343.
Knobloch, T., Harmrolfs, K., Taft, F., Thomaszewski, B., Sasse, F., and
Kirschning, A. (2011). Mutational biosynthesis of ansamitocin antibiotics: A
diversity-oriented approach to exploit biosynthetic flexibility. ChemBioChem
12, 540–547.
Kupchan, S.M., Sneden, A.T., Branfman, A.R., Howie, G.A., Rebhun, L.I.,
McIvor, W.E., Wang, R.W., and Schnaitman, T.C. (1978). Structural require-
ments for antileukemic activity among the naturally occurring and semisyn-
thetic maytansinoids. J. Med. Chem. 21, 31–37.
Lewis, R.J., Singh, O.M., Smith, C.V., Skarzynski, T., Maxwell, A., Wonacott,
A.J., and Wigley, D.B. (1996). The nature of inhibition of DNA gyrase by the
coumarins and the cyclothialidines revealed by X-ray crystallography. EMBO
J. 15, 1412–1420.
Lu, C., Bai, L., and Shen, Y. (2004). A novel amideN-glycoside of ansamitocins
from Actinosynnema pretiosum. J. Antibiot. 57, 348–350.
Ma, J., Zhao, P.J., and Shen, Y.M. (2007). New amideN-glycosides of ansami-
tocins identified from Actinosynnema pretiosum. Arch. Pharm. Res. 30,
670–673.
Miller, T.W., Goegelman, R.T., Weston, R.G., Putter, I., and Wolf, F.J. (1972).
Cephamycins, a new family of beta-lactam antibiotics. II. Isolation and chem-
ical characterization. Antimicrob. Agents Chemother. 2, 132–135.
Nagarajan, R., Boeck, L.D., Gorman, M., Hamill, R.L., Higgens, C.E., Hoehn,
M.M., Stark, W.M., and Whitney, J.G. (1971). Beta-lactam antibiotics from
Streptomyces. J. Am. Chem. Soc. 93, 2308–2310.
Neumann, A., Wohlfarth, G., and Diekert, G. (1996). Purification and character-
ization of tetrachloroethene reductive dehalogenase from Dehalospirillum
multivorans. J. Biol. Chem. 271, 16515–16519.
Snipes, C.E., Duebelbeis, D.O., Olson,M., Hahn, D.R., Dent,W.H., 3rd, Gilbert,
J.R., Werk, T.L., Davis, G.E., Lee-Lu, R., and Graupner, P.R. (2007). The ansa-
carbamitocins: polar ansamitocin derivatives. J. Nat. Prod. 70, 1578–1581.
Spiteller, P., Bai, L., Shang, G., Carroll, B.J., Yu, T.W., and Floss, H.G. (2003).
The post-polyketide synthase modification steps in the biosynthesis of the
antitumor agent ansamitocin by Actinosynnema pretiosum. J. Am. Chem.
Soc. 125, 14236–14237.
Steffensky, M., Mu¨hlenweg, A., Wang, Z.X., Li, S.M., and Heide, L. (2000).
Identification of the novobiocin biosynthetic gene cluster of Streptomyces
spheroides NCIB 11891. Antimicrob. Agents Chemother. 44, 1214–1222.
Wei, G.Z., Bai, L.Q., Yang, T., Ma, J., Zeng, Y., Shen, Y.M., and Zhao, P.J.
(2010). A new antitumour ansamitocin from Actinosynnema pretiosum. Nat.
Prod. Res. 24, 1146–1150.
Wu, Y., Kang, Q., Shang, G., Spiteller, P., Carroll, B., Yu, T.W., Su, W., Bai, L.,
and Floss, H.G. (2011a). N-methylation of the amide bond by methyltransfer-
ase asm10 in ansamitocin biosynthesis. ChemBioChem 12, 1759–1766.
Wu, Y., Kang, Q., Shen, Y., Su, W., and Bai, L. (2011b). Cloning and functional
analysis of the naphthomycin biosynthetic gene cluster in Streptomyces sp.
CS. Mol. Biosyst. 7, 2459–2469.
Xu, H., Heide, L., and Li, S.M. (2004). New aminocoumarin antibiotics formed
by a combined mutational and chemoenzymatic approach utilizing the carba-
moyltransferase NovN. Chem. Biol. 11, 655–662.
Yu, T.W., Bai, L., Clade, D., Hoffmann, D., Toelzer, S., Trinh, K.Q., Xu, J., Moss,
S.J., Leistner, E., and Floss, H.G. (2002). The biosynthetic gene cluster of the
maytansinoid antitumor agent ansamitocin from Actinosynnema pretiosum.
Proc. Natl. Acad. Sci. USA 99, 7968–7973.
Zhao, P., Bai, L., Ma, J., Zeng, Y., Li, L., Zhang, Y., Lu, C., Dai, H., Wu, Z., Li, Y.,
et al. (2008). AmideN-glycosylation by Asm25, anN-glycosyltransferase of an-
samitocins. Chem. Biol. 15, 863–874.Elsevier Ltd All rights reserved
